The share - Inify Laboratories

Inify Laboratories AB is listed on Euronext Growth Oslo since June 20th, 2022. All shares have equal rights and are freely transferable. Please follow the development of the Inify Laboratories share on Euronext Growth and view stock exchange releases at NewsWeb.

Euronext Growth

NewsWeb

Share information

Ticker code
Number of shares
Trading currency
Sector
ISIN
LEI code

INIFY
45,236,750
NOK
Health care
SE0017486103
549300306YYJ3BX3VB98

Shareholders

Inify Laboratories AB is listed on Euronext Growth Oslo under the ticker INIFY .
The list of total shares and the 20 largest shareholders is updated monthly, usually at month end. The last update was made on February 1st 2023. The company has a total of 45,236,750 outstanding shares.

Euronext Growth

20 largest shareholders

Number of shares held	Ownership (%)	Shareholder
27 183 726	60,09%	Gallivant S.á.r.l.
4 591 412	10,15%	Tauri AS
1 964 768	4,34%	Günther-Hanssen, Sven
1 872 414	4,14%	MP Pensjon PK
1 872 209	4,14%	Danske Bank A/S
894 543	1,98%	Bras Kapital AS
708 214	1,57%	Stavland, Bernt
648 167	1,43%	Stavland, Anders
434 316	0,96%	Swedbank AB
427 568	0,95%	Stavland, Per
336 950	0,74%	Monsun AS
332 971	0,74%	Vinterstua AS
309 922	0,69%	Avanza Bank AB
245 000	0,54%	Olsen, Lars Ejnar
200 000	0,44%	Sveen, Kristian
172 697	0,38%	Danske Bank A/S
171 016	0,38%	Skandinaviska Enskilda Banken AB
166 231	0,37%	Skjelbred, Rune
141 039	0,31%	B Stavland Holding AS
97 093	0,21%	Svenska Handelsbanken AB
2 466 494	5,45%	Others
45 236 750	100,00%	Total

Primary Insider Transactions

Information about primary insider transactions can be found under Investor news.

Dividend policy

The board of Inify Laboratories AB has not adopted a dividend policy since the Company considers itself to be in a growth phase, and therefore does not foresee that it will pay dividends in the near future. In deciding whether to propose a dividend and in determining the dividend amount, the Board of Directors will take into account legal restrictions as well as capital expenditure plans, financing requirements and maintaining the appropriate strategic flexibility.